Friday, October 2, 2015

Fair Game: Valeant’s High-Price Drug Strategy

Fair Game: Valeant’s High-Price Drug Strategy


Valeant, which has grown by acquiring rivals and slashing their staffs, has drawn the ire of a House panel, which is now considering a subpoena on the company’s price increases.










Read More…